We are experienced investors in Switzerland, owning 75% of MedyFin. Our business prioritizes early cash flow generation. Our interest in Healthcare businesses stems from its projected robust growth over the next decade. We collaborate with industry experts to identify key companies, evaluating them based on financial, market, and other distinctive data.
 
Our trading machines operate 24/7, leveraging years of historical data and reliable servers to automate profitable strategies and execution. Additionally, we extend the opportunity for outside investors to participate in MedyFin through equity ownership.

 

We are excited about the growth prospects of Healthcare companies. We are currently inviting investors to share up to 25% ownership in MedyFin.